Found 10 matching trials
Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine PHASE3 A migraine is a moderate to severe headache on one side of the head. A migr...
Show More Location
Tokyo Dental College Ichikawa General Hospital /ID# 247436
Learn More & Join Trial
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years PHASE3 Migraine is a disease that most often causes moderate to severe headache on...
Show More Location
Rehabilitation and Neurological Services /ID# 270782
Learn More & Join Trial
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine PHASE3 A migraine attack is a moderate or severe headache that usually occurs on o...
Show More Status
Active Not Recruiting
Location
Premier Health - Centerville /ID# 267023
Learn More & Join Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine PHASE3 This study evaluated the efficacy, safety and tolerability of atogepant in ...
Show More Location
Barrow Neuro Institute /ID# 236776
Learn More & Join Trial
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine PHASE3 A migraine is a moderate to severe headache on one side of the head that ma...
Show More Location
Medizinische Universitaet Wien /ID# 247119
Learn More & Join Trial
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine PHASE3 A migraine is a moderate to severe headache on one side of the head. A migr...
Show More Location
Rehabilitation & Neurological Services /ID# 248517
Learn More & Join Trial
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine PHASE3 A migraine attack is a moderate or severe headache that usually occurs on o...
Show More Status
Active Not Recruiting
Location
Universitair Ziekenhuis Antwerpen /ID# 257582
Learn More & Join Trial
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention PHASE2 This study will evaluate the safety and tolerability of the following doses...
Show More Location
Achieve Clinical Research
Learn More & Join Trial
Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. PHASE3 This study will assess the safety, tolerability, and efficacy of Atogepant ...
Show More Location
Axiom Research /ID# 226379
Learn More & Join Trial
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine PHASE3 To evaluate the safety and tolerability of atogepant 30 mg and 60 mg once a...
Show More Location
Synexus Clinical Research US, Inc.
Learn More & Join Trial